Tag: Ticagrelor

ACS: Necessary DAPT after PCI may be shorter than currently advised

Presented By
Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
ULTIMATE-DAPT
Conference
ACC 2024
Type
Peer-reviewed article

16 May 2024 13:29

Evolving evidence for P2Y12 inhibition in chronic coronary syndromes: PANTHER

Presented By
Prof. Marco Valgimigli, Cardiocentro Ticino Foundation, Switzerland
Trial
PANTHER
Conference
ESC 2022
Type
Peer-reviewed article

27 October 2022 13:55

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By
Prof. Jeffrey Berger, New York University Langone, USA
Trial
ACTIV-4A
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 16:30

Long-term reduced risk of CV events with ticagrelor plus aspirin after CABG

Presented By
Dr Qiang Zhao, Shanghai Jiao Tong University, China
Trial
DACAB-FE
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 16:17

Ticagrelor cessation: early CABG non-inferior to delayed surgery

Presented By
Dr Derek So, University of Ottowa Heart Institute, Canada
Trial
RAPID CABG
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 15:30

REVERSE-IT: Interim analysis shows promising effect of bentracimab on ticagrelor reversal

Presented By
Dr Deepak Bhatt, Brigham and Women’s Hospital, USA
Trial
Phase 3, REVERSE-IT
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 14:12

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By
Dr Birgit Vogel, Icahn School of Medicine, USA
Trial
TWILIGHT
Conference
ACC 2021
Type
Peer-reviewed article

9 July 2021 23:24

Ticagrelor/aspirin reduces stroke risk in patients with ipsilateral cervicocranial plaque

Presented By
Prof. Pierre Amarenco, Paris University, France
Trial
THALES
Conference
AHA 2020

18 February 2021 11:01

Ticagrelor not superior to clopidogrel after elective PCI

Presented By
Prof. Johanne Silvain, Sorbonne University, France
Trial
Phase 3, ALPHEUS
Conference
AHA 2020
Type
Peer-reviewed article

18 February 2021 10:43

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By
Prof. Y.S. Jang, Yonsei University, South Korea
Trial
TICO
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By
Prof. D. Angiolillo, University of Florida - Jacksonville, USA
Trial
TWILIGHT, TWILIGHT-DM
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:24

TWILIGHT sub-study: complex PCI patients

Presented By
Prof. G. Dangas, Icahn School of Medicine at Mount Sinai, USA
Trial
TWILIGHT
Conference
ACC 2020
Type
Peer-reviewed article

8 September 2020 15:20

TAILOR-PCI misses endpoint but still provides valuable insights

Presented By
Prof. N. Pereira, Mayo Clinic, USA
Trial
TAILOR-PCI
Conference
ACC 2020
Type
Peer-reviewed article

7 September 2020 23:16

Drop aspirin after 3 months in non-STEMI ACS patients on dual antiplatelet therapy

Presented By
Prof. Usman Baber, Icahn School of Medicine at Mount Sinai, USA
Trial
TWILIGHT
Conference
AHA 2019
Type
Peer-reviewed article

26 February 2020 20:58

Ticagrelor monotherapy safe after dual antiplatelet therapy

Trial
GLASSY; GLOBAL LEADERS
Conference
ACC 2019
Type
Peer-reviewed article

6 June 2019 12:34
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com